Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy

N Engl J Med. 2024 Feb 15;390(7):584-586. doi: 10.1056/NEJMp2400209. Epub 2024 Jan 24.

Authors

Nicole Verdun¹, Peter Marks¹

Affiliation

¹ From the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

PMID: 38265704
DOI: 10.1056/NEJMp2400209

No abstract available

MeSH terms

Cell- and Tissue-Based Therapy / adverse effects
Humans
Immunotherapy, Adoptive* / adverse effects
Neoplasms, Second Primary* / etiology
Receptors, Antigen, T-Cell / genetics
Receptors, Antigen, T-Cell / therapeutic use
Receptors, Chimeric Antigen* / therapeutic use

Substances

Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen